Eotaxin levels and eosinophils in guinea pig broncho‐alveolar lavage fluid are increased at the onset of a viral respiratory infection

In previous studies we found that guinea pigs demonstrate an increase in airway reactivity and eosinophil numbers 4 days after a respiratory infection with parainfluenza‐3 (PI3) virus. Clinical data support the possible involvement of eosinophils in virus‐induced airway hyperresponsiveness. Eotaxin, a newly discovered chemokine, could be involved in eosinophil migration to the airways. In this study, eosinophil numbers were counted in blood and bronchoalveolar lavage (BAL) fluid and related with eotaxin concentrations in BAL fluid 1, 2, 3, and 4 days after intratracheal PI3 virus administration. On day 1, blood eosinophils increased by more than 200% (P < 0.01). The number of eosinophils were only slightly enhanced from day 2 to day 4 (40%–70%). BAL fluid eosinophils were not increased on day 1 but were significantly elevated on day 2 (180%) and remained high on days 3–4 (>300%, P < 0.05). This increase in lung eosinophils correlated well with eotaxin levels measured in BAL fluid. There was no significant increase in eotaxin on day 1 following PI3 infection; however, on days 2–4 eotaxin levels in BAL fluid were significantly elevated (four–sixfold increase) when compared with medium inoculated controls. Eotaxin appears to play an important role in eosinophil accumulation in guinea pig lung following PI3 infection.

[1]  G. Canonica,et al.  Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[2]  W. Busse,et al.  Virus-induced airway hyperresponsiveness and asthma. , 1998, American journal of respiratory and critical care medicine.

[3]  G. Canonica,et al.  Loratadine reduces the expression of ICAM‐1 , 1998, Allergy.

[4]  G. Canonica,et al.  Continuous versus on demand treatment with cetirizine for allergic rhinitis. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  Q. Hamid,et al.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.

[6]  G. Canonica,et al.  Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM‐1 expression , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[8]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[9]  S. Rankin,et al.  Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.

[10]  E. D. de KLERK,et al.  Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[11]  G. Canonica,et al.  Seasonal rhinitis and azelastine: long- or short-term treatment? , 1997, The Journal of allergy and clinical immunology.

[12]  G. Canonica,et al.  Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti‐allergic activity , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  G. Canonica,et al.  Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. , 1996, The Journal of allergy and clinical immunology.

[14]  G. Canonica,et al.  Topical ocular levocabastine reduces ICAM‐1 expression on epithelial cells both in vivo and in vitro , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[16]  G. Canonica,et al.  Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. , 1996, International archives of allergy and immunology.

[17]  G. Canonica,et al.  Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. , 1995, The Journal of allergy and clinical immunology.

[18]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[19]  G. Canonica,et al.  Terfenadine exerts antiallergic activity reducing ICAM‐1 expression on nasal epithelial cells in patients with pollen allergy , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[21]  G. Canonica,et al.  ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. , 1995, International archives of allergy and immunology.

[22]  S. Johnston,et al.  Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[23]  G. Canonica,et al.  Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. , 1995, The Journal of allergy and clinical immunology.

[24]  G. Canonica,et al.  Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. , 1994, American journal of respiratory and critical care medicine.

[25]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[26]  G. Canonica,et al.  Adhesion molecules of allergic inflammation: recent insights into their functional roles , 1994, Allergy.

[27]  T. Williams,et al.  The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. , 1993, Biochemical and biophysical research communications.

[28]  T. Lee,et al.  Adhesion molecules in allergic inflammation. , 1993, The American review of respiratory disease.

[29]  R. Sorva,et al.  Serum eosinophil cationic protein during treatment of asthma in children. , 1993, The Journal of allergy and clinical immunology.

[30]  G. Folkerts,et al.  Virus-induced changes in airway responsiveness, morphology, and histamine levels in guinea pigs. , 1993, The American review of respiratory disease.

[31]  P. Span,et al.  Virus‐induced airway hyperresponsiveness in the guinea‐pig: possible involvement of histamine and inflammatory cells , 1993, British journal of pharmacology.

[32]  G. Canonica,et al.  Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. , 1993, The Journal of allergy and clinical immunology.

[33]  G. Folkerts,et al.  Virus-induced airway hyperresponsiveness in guinea pigs in vivo: study of broncho-alveolar cell number and activity. , 1992, European journal of pharmacology.

[34]  R. Lockey,et al.  A possible role for adhesion molecules in asthma. , 1992, The Journal of allergy and clinical immunology.

[35]  C. Wegner,et al.  The role of intercellular adhesion molecule‐1 in chronic airway inflammation , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[36]  I. Weissman,et al.  Selectins: A family of adhesion receptors , 1991, Cell.

[37]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[38]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[39]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[40]  A. Vecchione,et al.  Inflammatory changes in conjunctival scrapings after allergen provocation in humans. , 1988, The Journal of allergy and clinical immunology.

[41]  H. Kita,et al.  In Vitro: Synergistic Effects of Platelet-activating Factor and Eosinophil-active Cytokines , 1997 .

[42]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[43]  G. Folkerts,et al.  Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. , 1995, The Journal of clinical investigation.

[44]  I. van Ark,et al.  Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. , 1995, American journal of respiratory and critical care medicine.

[45]  S. Bonini,et al.  17 Late-phase ocular reaction induced by conjunctival allergen challenge. A dose-response study in humans , 1988 .